The new law bans the use of AI for mental health and therapeutic decision-making, but states it can be used for ...

The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.

Global healthcare venture fund OrbiMed announced it raised $1.86 billion for Healthcare Royalty and Credit Fund V to invest in growth-oriented companies.

The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second quarter earnings.

The company will use the funds to scale its reach within the U.S and to expand access to its offerings globally.

The acquisition comes just months after Cerebral reached a settlement with the FTC over allegations of deceptive subscription and data-sharing practices.

When implementing AI-powered assistants and ambient technologies, it is essential to know if what you are buying is an actual assistant and if it has features beyond just clinical documentation, says ...

The company aims to help providers secure stable pricing and access products and services for patients seeking reproductive and sexual healthcare.

The company said it plans to expand U.S. access to its services while growing its pipeline to include additional cardiac ...

b.well joins the more than 60 companies, including industry giants Amazon , Apple , Google , OpenAI, Oura and Hippocratic AI ...

The alliance will integrate AI-powered health agents into Eucalyptus' portfolio, including the company's Juniper weight ...